1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Menicon Co., Ltd.

Menicon Co., Ltd.

10.20
EUR
0.00
(0.00%)
Nov 13Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
951.56
965.66
946.22
1,016.38
1,091.79
1,149.32
1,168.09
1,141.82
1,324.8
1,452.55
1,527.29
1,600.07
1,355.2
- -
Basic EPS, GAAP
15.46
21.9
31.26
35.87
37.83
50.8
56.11
78.83
85.71
97.24
59.65
73.71
63.83
- -
Free Cash Flow per Basic Share
-49.77
10.2
50.87
20.59
43.39
25.87
30.89
-16.52
-42.68
-2.98
-124.45
-46.68
-50.27
- -
Dividend per Share
6.25
7.5
6.89
7.74
9.47
12.47
13.63
13.97
17.47
20.02
24.99
25.08
23.14
- -
Book Value per Share
462.95
473.57
524.59
536.48
569.77
603.26
708.57
806.2
884.09
982.05
1,072.66
1,133.5
1,280.95
- -
Tangible Book Value per Share
314.09
344.35
414.6
412.19
463.91
514.75
614.95
639.13
731
831.08
919.56
928.12
1,097.33
- -
Basic Weighted Avg Shares
65
65
71
71
70
70
72
76
76
76
76
76
93
75
Sales/Revenue/Turnover
62,209
63,131
67,332
72,052
76,672
80,898
84,519
86,209
100,172
110,194
116,192
121,491
125,605
- -
Operating Margin (%)
3.69
4.54
5.14
5.43
5.73
6.89
8.32
9.4
9.94
10.95
7.7
8.24
8.15
- -
Depreciation Expense
3,774
4,198
4,365
4,653
5,007
4,640
5,421
6,028
7,293
7,448
7,947
8,445
10,817
- -
Net Income, GAAP
1,011
1,431
2,224
2,543
2,657
3,576
4,060
5,952
6,481
7,377
4,538
5,597
5,916
- -
Effective Tax Rate (%)
61.33
50.01
43.28
38.18
38.13
37.49
35.13
28.73
34.53
35.93
36.16
39.67
33.19
- -
Profit Margin (%)
1.63
2.27
3.3
3.53
3.47
4.42
4.8
6.9
6.47
6.69
3.91
4.61
4.71
- -
Working Capital
11,231
11,026
15,136
16,493
19,392
24,016
19,971
47,677
41,500
53,349
35,718
56,177
49,772
- -
LT Debt
15,609
15,669
11,918
15,433
10,590
15,060
9,368
40,338
37,636
49,938
44,579
71,856
67,702
- -
Total Equity
33,149
33,873
38,440
37,678
40,120
42,548
53,519
60,981
67,042
74,663
81,802
86,126
95,103
- -
Return on Invested Capital (%)
- -
2.65
3.54
4.23
4.7
5.78
6.95
6.55
5.95
6.42
4.03
3.81
4.09
- -
Return on Capital (%)
- -
3.05
4.47
4.78
4.88
6.26
6.51
7.06
6.21
6.4
3.49
3.84
3.91
- -
Return on Common Equity (%)
- -
4.28
6.16
6.68
6.84
8.66
8.46
10.41
10.13
10.42
5.8
6.67
6.53
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
6,867
6,477
- -
LT Borrowings
64,161
62,288
- -
LT Finance Leases
5,699
5,414
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
74
74
74
Market Capitalization
- -
- -
- -

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
78,061
78,978
- -
Cash, Cash Equivalents & STI
35,827
32,608
- -
Accounts Receivable, Net
14,294
14,794
- -
Inventories
22,529
26,444
- -
Total Current Liabilities
27,666
29,206
- -
Payables & Accruals
- -
- -
- -
ST Debt
6,867
6,477
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.69%
9.32%
10.42%
Free Cash Flow
399.98%
824.81%
31.46%
Net Income, GAAP
12.68%
2.66%
5.7%
Sales/Revenue/Turnover
6.5%
7.92%
3.39%
Total Cash Common Dividend
16.26%
15.63%
12.66%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
121,491
2026
- -
- -
- -
- -
125,605
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
73.71
2026
- -
- -
- -
- -
63.83
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
25.08
2026
- -
- -
- -
- -
23.14
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Koji Kawaura
Full Time Employees
4,493
Sector
Health technology
Industry
Medical specialties
Address
3-21-19, Aoi Nagoya AI Japan 460-0006
IPO Date
Jun 25, 2015
Website
menicon.co.jp
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Menicon Co., Ltd. is a Japanese company primarily engaged in the manufacture and sale of contact lenses and related eye care products. Its core product offerings include rigid gas permeable (RGP) lenses, soft contact lenses, daily disposable lenses, multifocal lenses, and orthokeratology lenses, as well as lens care solutions such as cleaning, disinfecting, and moisturizing products. Menicon also provides ophthalmic services and vision care support equipment. The company operates extensively in Japan and has expanded its presence internationally, including markets in Asia, Europe, and North America. Founded in 1951, Menicon is headquartered in Nagoya, Japan. Recent major developments at Menicon include strategic partnerships and expansions aimed at enhancing its product portfolio and geographic reach. Within the last two years, Menicon has advanced its orthokeratology lens technology and increased investment in R&D to launch innovative lens materials and designs. The company has also pursued collaborations in the fields of eye health technology and digital vision care services, aligning with trends toward integrated eye care. Menicon continues to focus on diversifying its product line and expanding its service offerings to meet evolving customer needs in the global contact lens market, maintaining a leadership position through innovation and quality. Menicon's business segments primarily cover contact lens manufacturing and sales, eye care products, and related services targeting both individual consumers and healthcare professionals. The company’s diversified product range and ongoing innovation initiatives position it as a significant player in the optical and eye care industry worldwide. It operates subsidiaries in several countries to support its international sales and service network. Menicon’s systematic approach includes product development, market expansion, and strategic collaborations to sustain growth in competitive markets.